BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 9529259)

  • 1. Conservation of structure and mechanism between eukaryotic topoisomerase I and site-specific recombinases.
    Cheng C; Kussie P; Pavletich N; Shuman S
    Cell; 1998 Mar; 92(6):841-50. PubMed ID: 9529259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccinia virus DNA topoisomerase: a model eukaryotic type IB enzyme.
    Shuman S
    Biochim Biophys Acta; 1998 Oct; 1400(1-3):321-37. PubMed ID: 9748643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of a bacterial type IB DNA topoisomerase reveals a preassembled active site in the absence of DNA.
    Patel A; Shuman S; Mondragón A
    J Biol Chem; 2006 Mar; 281(9):6030-7. PubMed ID: 16368685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catalytic mechanism of DNA topoisomerase IB.
    Krogh BO; Shuman S
    Mol Cell; 2000 Jun; 5(6):1035-41. PubMed ID: 10911997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A newly identified, essential catalytic residue in a critical secondary structure element in the integrase family of site-specific recombinases is conserved in a similar element in eucaryotic type IB topoisomerases.
    Cao Y; Hayes F
    J Mol Biol; 1999 Jun; 289(3):517-27. PubMed ID: 10356326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A poxvirus-like type IB topoisomerase family in bacteria.
    Krogh BO; Shuman S
    Proc Natl Acad Sci U S A; 2002 Feb; 99(4):1853-8. PubMed ID: 11830640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two tricks in one bundle: helix-turn-helix gains enzymatic activity.
    Grishin NV
    Nucleic Acids Res; 2000 Jun; 28(11):2229-33. PubMed ID: 10871343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An insight into the active site of a type I DNA topoisomerase from the kinetoplastid protozoan Leishmania donovani.
    Das A; Mandal C; Dasgupta A; Sengupta T; Majumder HK
    Nucleic Acids Res; 2002 Feb; 30(3):794-802. PubMed ID: 11809893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure of the amino-terminal fragment of vaccinia virus DNA topoisomerase I at 1.6 A resolution.
    Sharma A; Hanai R; Mondragón A
    Structure; 1994 Aug; 2(8):767-77. PubMed ID: 7994576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical and traditional mutagenesis of vaccinia DNA topoisomerase provides insights to cleavage site recognition and transesterification chemistry.
    Yakovleva L; Chen S; Hecht SM; Shuman S
    J Biol Chem; 2008 Jun; 283(23):16093-103. PubMed ID: 18367446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individual nucleotide bases, not base pairs, are critical for triggering site-specific DNA cleavage by vaccinia topoisomerase.
    Tian L; Sayer JM; Jerina DM; Shuman S
    J Biol Chem; 2004 Sep; 279(38):39718-26. PubMed ID: 15252055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of DNA Binding by the Isolated N-Terminal Domain of Vaccinia Virus DNA Topoisomerase IB.
    Reed B; Yakovleva L; Shuman S; Ghose R
    Biochemistry; 2017 Jul; 56(26):3307-3317. PubMed ID: 28570045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a minimal functional linker in human topoisomerase I by domain swapping with Cre recombinase.
    Frøhlich RF; Juul S; Nielsen MB; Vinther M; Veigaard C; Hede MS; Andersen FF
    Biochemistry; 2008 Jul; 47(27):7127-36. PubMed ID: 18553933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of DNA transesterification by vaccinia topoisomerase: catalytic contributions of essential residues Arg-130, Gly-132, Tyr-136 and Lys-167.
    Wittschieben J; Shuman S
    Nucleic Acids Res; 1997 Aug; 25(15):3001-8. PubMed ID: 9224599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conservation of structure and function among tyrosine recombinases: homology-based modeling of the lambda integrase core-binding domain.
    Swalla BM; Gumport RI; Gardner JF
    Nucleic Acids Res; 2003 Feb; 31(3):805-18. PubMed ID: 12560475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccinia topoisomerase and Cre recombinase catalyze direct ligation of activated DNA substrates containing a 3'-para-nitrophenyl phosphate ester.
    Woodfield G; Cheng C; Shuman S; Burgin AB
    Nucleic Acids Res; 2000 Sep; 28(17):3323-31. PubMed ID: 10954601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catalytic residues of the telomere resolvase ResT: a pattern similar to, but distinct from, tyrosine recombinases and type IB topoisomerases.
    Deneke J; Burgin AB; Wilson SL; Chaconas G
    J Biol Chem; 2004 Dec; 279(51):53699-706. PubMed ID: 15471873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Teaching a new dog old tricks?
    Wigley DB
    Structure; 1998 May; 6(5):543-8. PubMed ID: 9634692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polynucleotide ligase activity of eukaryotic topoisomerase I.
    Shuman S
    Mol Cell; 1998 Apr; 1(5):741-8. PubMed ID: 9660957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational analysis of 26 residues of vaccinia DNA topoisomerase identifies Ser-204 as important for DNA binding and cleavage.
    Wang LK; Wittschieben J; Shuman S
    Biochemistry; 1997 Jul; 36(26):7944-50. PubMed ID: 9201940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.